Gan & Lee partners with IDF to expand its diabetes treatment portfolio

By Nikita Chaurasia  | Date: 2021-02-23

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

China-based leading pharmaceutical organization Gan & Lee Pharmaceuticals Co. Ltd. has announced to have signed a strategic collaboration with the International Diabetes Federation (IDF) to bolster its efforts towards promoting the prevention and care of diabetes across the globe.

For the uninitiated, the International Diabetes Federation is an umbrella organization that comprises around 230 national diabetes associations across more than 160 territories and countries. The group represents the interests of the growing population of diabetics as well as those at risk.

The partnership between the two organizations will open doors that will bolster future initiatives such as medical education by leveraging the global reach of IDF School of Diabetes. Gan & Lee Pharmaceuticals also intends on becoming a founding partner for the launch of the IDF WeChat platform in China, as cited by credible sources.

CEO of Gan & Lee Pharmaceuticals, Kai Du was reported saying that the joint venture with IDF will assist the company in reinforcing its global outreach and advocacy programs aimed at improving the lives of individuals affected by diabetes.

Expressing his enthusiasm towards the partnership, Prof. Andrew Boulton, President of IDF commented that the association looks forward to collectively offering affordable and uninterrupted care as well as education for diabetic patients across the globe.

Acknowledging the multidimensional nature of diabetes care, Gan & Lee claim to understand the significance of supporting advocacy initiatives and online educational resources. Moving forward, the company will be working towards offering cost-efficient, intensive care and education regarding diabetes, sources confirmed.

About Gan & Lee Pharmaceuticals

Gan & Lee Pharmaceuticals is a Beijing-headquartered organization that primarily focuses on the manufacture and distribution of pharmaceutical products. The company’s product portfolio includes synthetic human insulins, insulin glargine injections, insulin materials, and medical equipment.

Source credits –

https://www.prnewswire.com/in/news-releases/gan-amp-lee-announces-new-partnership-with-international-diabetes-federation-818317920.html#:~:text=BEIJING%20and%20BRIDGEWATER%2C%20N.J.%2C%20Feb,aims%20to%20support%20their%20global

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

Swiftly achieves Unicorn status with $100M Series C led by BRV Capital

Swiftly achieves Unicorn status with $100M Series C led by BRV Capital

By Nikita Chaurasia

Swiftly Systems has reportedly achieved unicorn status, securing in funding through a Series C round. The prominent BRV Capital Management led this funding initiative. According to the earlier reports, Swiftly was adopted by hundreds of consumer b...

Rainforest nations unify to demand cash for climate & biodiversity preservation

Rainforest nations unify to demand cash for climate & biodiversity preservation

By Nikita Chaurasia

As per the reports, twelve nations with rainforests united to establish a collective initiative aiming to address climate change and safeguard biodiversity at summit held in Brazil. The declaration, titled "United for Our Forests," emerged ...

AI Chatbot, Llama 2, unveiled by Meta for commercial use via Microsoft

AI Chatbot, Llama 2, unveiled by Meta for commercial use via Microsoft

By Nikita Chaurasia

Meta Platforms has recently introduced Llama 2, an artificial intelligence large language model, for commercial use in collaboration with major cloud providers like Microsoft. Instead of charging for access or usage, Meta aims to share the model with...

Moderna signs agreement to explore mRNA medicines in China

Moderna signs agreement to explore mRNA medicines in China

By Nikita Chaurasia

Moderna Inc, a leading vaccine manufacturer, reportedly announced on Wednesday that it has entered into a memorandum of understanding (MoU) and a land collaboration agreement aimed at exploring opportunities for researching, developing, and producing...

Nike and Epic Games collaborate to launch Airphoria NFT in Fortnite

Nike and Epic Games collaborate to launch Airphoria NFT in Fortnite

By Nikita Chaurasia

The American footwear design & manufacturing company, Nike and Epic Games, the creators of the popular online game Fortnite, have joined forces in an exciting new collaboration. The partnership aims to bring about a groundbreaking change in the d...